The FDA has issued an urgent warning for dog owners and vets about a widely used painkiller that's given to dogs with ...

A study revealed that the use of a popular arthritis medication for dogs may cause severe neurological side effects.

The biotech will stop developing two drugs and lay off nearly three-quarters of its staff after its lead therapy wasn’t as ...

A popular drug for dogs with arthritis may be associated with a variety of potentially severe neurological effects, including seizures and a loss of muscle control, according to a recent review by ...

GCC-4001 is under clinical development by Artiva Biotherapeutics and currently in Phase I for Rheumatoid Arthritis.

The drug Librela seemed like a miracle drug when it came onto the market, but the FDA has a new warning for vets about side effects. The FOX 5 I-Team's Dana Fowle takes a closer look at the warning.

The GLP-1s include semaglutide (Ozempic, Wegovy) and the combination of GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound).

SCAR-02 is under clinical development by Hunan Siweikang Therapeutics and currently in Phase II for Rheumatoid Arthritis.

Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, today announced ...

"Every time I walk in this door it's like there's something missing," Weaver said. In May Weaver brought Perry to her veterinarian because he had a mild case of arthritis. The dog was prescribed a ...

In May Weaver brought Perry to her veterinarian because he had a mild case of arthritis. The dog was prescribed a drug called Librela to treat it. "I was told there's this new drug," Weaver said.